
Monday, February 12, 2018 11:00:31 AM
At least we now know they have enough cash to make it to the end of this Phase 3 trial. That alone will be the catalyst for this company to either rocket to stardom, or file for bankruptcy! For now, I shall let it ride. I have my orders in for another 1M if people start to panic sell...lol
If .03 holds today, I think we are in good shape!
IMHO
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent DCTH News
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 03/31/2023 03:32:01 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/30/2023 01:00:54 PM
- Delcath Systems Announces Closing of Private Placement of up to $85 Million • PR Newswire (US) • 03/30/2023 01:41:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/28/2023 10:04:20 AM
- Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update • PR Newswire (US) • 03/27/2023 12:20:00 PM
- Delcath Systems Announces up to $85 Million Financing • PR Newswire (US) • 03/27/2023 12:15:00 PM
- Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023 • PR Newswire (US) • 03/27/2023 12:10:00 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/27/2023 12:00:48 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 02/27/2023 10:00:16 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/24/2023 11:08:32 AM
- Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch • PR Newswire (US) • 02/16/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/14/2023 03:59:47 PM
- Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit • PR Newswire (US) • 02/14/2023 01:49:00 PM
- Delcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16 • PR Newswire (US) • 01/30/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/23/2023 12:01:47 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:04 AM
- Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology • PR Newswire (US) • 01/17/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/10/2023 09:13:57 PM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 01/10/2023 09:08:24 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 12/29/2022 10:28:09 PM
- Tender Offer Statement by Issuer (sc To-i) • Edgar (US Regulatory) • 12/21/2022 05:18:41 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 12/16/2022 10:07:45 PM
- Delcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4) • PR Newswire (US) • 12/16/2022 09:15:00 PM
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 12/16/2022 08:04:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/16/2022 02:32:48 PM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM